Warsame, Marian
Hassan, Abdillahi Mohamed
Hassan, Abdikarim Hussein
Jibril, Ali Mohamed
Khim, Nimol
Arale, Abdulkadir Mohamed
Gomey, Ahamed Hassan
Nur, Zainab Said
Osman, Said Mohamed
Mohamed, Marian Said
Abdulrahman, Ali
Yusuf, Fahmi Essa
Amran, Jamal Ghilan Hefzullah
Witkowski, Benoit
Ringwald, Pascal
Clinical trials referenced in this document:
Documents that mention this clinical trial
High therapeutic efficacy of artemether–lumefantrine and dihydroartemisinin–piperaquine for the treatment of uncomplicated falciparum malaria in Somalia
https://doi.org/10.1186/s12936-019-2864-1
Documents that mention this clinical trial
High therapeutic efficacy of artemether–lumefantrine and dihydroartemisinin–piperaquine for the treatment of uncomplicated falciparum malaria in Somalia
https://doi.org/10.1186/s12936-019-2864-1
Funding for this research was provided by:
Bill and Melinda Gates Foundation (OPP1140599)
Article History
Received: 20 March 2019
Accepted: 3 July 2019
First Online: 11 July 2019
Ethics approval and consent to participate
: The study protocol was approved by the Ministry of Health Federal Government of Somalia, the Ministry of Health of Puntland and the WHO Research Ethics Review Committee (ERC0002740, ERC0002915). In Jowhar, community leaders of the study villages were informed about the study objectives and procedures and gave their permission. Adult patients or parents/guardians of study children provided written consent prior to enrolment. In addition to consent from parents/guardians, children aged ≥ 12 years provided assent.
: Not applicable.
: The authors declare that they have no competing interests.